Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. vs. Gilead Pharmasset LLC et al.
Explore the PTAB proceeding IPR2018-00103 filed by Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. on 2017-10-25. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-00103
Filing Date
2017-10-25
Accorded Filing Date
2017-10-25
Institution Decision Date
2018-06-13
Last Modified Date
—
Proceeding Type
IPR
Termination Date
—
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Patent Owner / Respondent
Gilead Pharmasset LLC et al.
Represented By
Whelan, Dorothy et alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 25512 | Pasquale Razzano | +1 212-218-2100 |
| 27276 | Anthony Zupcic | +1 212-218-2100 |
| 29296 | Leonard Diana | +1 212-218-2100 |
| 29836 | John Murnane | +1 212-218-2527 |
| 31530 | Nicholas Kallas | +1 212-218-2243 |
| 31865 | Lawrence Perry | +1 212-218-2293 |
| 32433 | Scott Reed | +1 212-218-2227 |
| 32533 | Scott Malpede | +1 202-530-1010 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Idenix Pharmaceuticals LLC v. Gilead Pharmasset LLC